Baxter International Inc.
BAXStock
$23.35−21.59%52W
Market Cap$11.94B
P/E—
Div yield0.18%
Beta0.61
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-0.88%
Price vs S&P 500 (4W)7.66%
VGM Score48.74
Market Capitalization$11.94B
Indicated Dividend Yield (Annual)0.18%
Earnings Surprise History
Q1 260.36est. 0.31
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
3.23
3.23
2.67
2.71
Industry Peers — Surgical & Medical Instruments(141)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
BAXBaxter International Inc. | B | F | C | $23.35 |
| SYKStryker Corporation | C | C | D | $331.20 |
| MMM3M Company | C | F | B | $161.77 |
| BSXBoston Scientific Corp. | C | B | F | $44.62 |
| MDLNMedline Inc. Class A common stock | C | D | D | $41.11 |
| BDXBecton, Dickinson and Co. | B | C | B | $159.93 |
| DXCMDexCom, Inc. | C | B | C | $77.98 |
| RMDResMed Inc. | C | B | D | $202.76 |
| WSTWest Pharmaceutical Services, Inc. | D | C | A | $362.44 |
| SOLVSolventum Corporation | C | D | B | $81.70 |
| PENPenumbra, Inc. | F | C | B | $319.60 |
About
Baxter supplies medical devices and therapies to hospitals and care settings, including injectable products, IV systems, nutritional solutions, and surgical sealants. The company expanded its hospital equipment portfolio through its 2021 Hillrom acquisition and divested its kidney care business in early 2025.